About
Scanogen Inc. is a molecular diagnostic company located in Baltimore, Maryland. The company focuses on developing rapid and user-friendly diagnostic systems that enhance healthcare outcomes by providing access to biomolecular information from body fluids. Its proprietary technology, known as Single Molecule And Rapid Tethering (SMART) or Single MOLecule Tethering (SMOLT), enables ultra-sensitive and rapid detection of biomolecules. This technology supports a sample-to-answer diagnostic platform designed for point-of-care use, particularly for the rapid diagnosis of bloodstream infections like sepsis. The core product features an automated instrument with disposable test cartridges, a touchscreen interface, and a barcode scanner. Users can insert a blood sample into the cartridge, and the instrument processes it automatically, delivering quick results. Scanogen is also developing a suite of point-of-care tests, including a Sepsis-ID test that identifies microbial species causing sepsis directly from whole blood. The platform is designed for use in clinical microbiology laboratories and other healthcare settings that require rapid pathogen identification.
Technologies
Keywords
Company Information
-
Employees 20
-
Founded 2011
-
Annual Revenue $310000
-
Total Funding $2900000
Location
3102 Lord Baltimore Drive, Milford Mill, Maryland, United States, 21244